NPWTi on Closure of Chronic Pressure Sores
Evaluation of Vacuum-Assisted Closure Veraflo Therapy With Cleanse Choice Dressing on Wound Healing in Patients With Pressure Sores: A Prospective, Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Robert Galiano, MD
- Phone Number: 3129267037
- Email: robert.galiano@nm.org
Study Contact Backup
- Name: Kristin Huffman, B.S.
- Phone Number: 3129267037
- Email: kristin.huffman@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern University
-
Contact:
- Robert Galiano, MD
- Phone Number: 3129267037
- Email: robert.galiano@nm.org
-
Contact:
- Kristin Huffman
- Phone Number: 3129267037
- Email: kristin.huffman@northwestern.edu
-
Principal Investigator:
- Robert Galiano, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ischial and sacral wounds at stage 3 and 4.
- Any pressure sore that has the potential for a good seal.
Exclusion Criteria:
- Any pressure sore that does not have potential for a good seal.
- Patients with fecal incontinence (due to potential for pressure sore to be near the anus).
- Patients who by the opinion of the Principal Investigator are not candidates for surgical closure (age, BMI, comorbidities, etc.).
- Patients who are pregnant. This is standard of care for surgery anyway, and there is uncertainty of how both the surgery and intervention would affect the fetus. We therefore stress any form of birth control, abstinence, and method to prevent pregnancy for those enrolled in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Control (Wet-to-dry dressings)
Subjects randomized to the control group with receive standard of care (wet-to-dry dressings) for treatment of their pressure sore.
|
Wet-to-dry dressings
|
|
Experimental: Treatment (NPWT with Instillation)
Subjects who are randomized into the treatment arm (NPWT with Instillation) will receive the V.A.C. VeraFlo™ Cleanse Choice Dressing Systems for treatment of their pressure sore.
|
The V.A.C.Ulta™ Negative Pressure Wound Therapy System is a 510(k) - cleared, Class II device (K100657) with the following indication for use: "the V.A.C.Ulta™ Negative Pressure Wound Therapy System is an integrated wound management system that provides Negative Pressure Wound Therapy with an instillation option.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Length of Stay
Time Frame: up to 3 months
|
Record the number of days spent in the hospital from initial debridement (first visit with plastic surgeon) to discharge from hospital following surgery
|
up to 3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost Analysis
Time Frame: Through study completion, approximately 5 months
|
Total costs of dressings, hospital stay, direct patient care and other costs involved in inpatient care.
|
Through study completion, approximately 5 months
|
|
Number of debridements
Time Frame: Through study completion, approximately 5 months
|
Record the total number of debridements performed at the wound site throughout the duration of the study
|
Through study completion, approximately 5 months
|
|
Successful closure of pressure sores
Time Frame: 2 weeks and 6 weeks post-closure surgery
|
Patients will be assessed for proper closure of the wound
|
2 weeks and 6 weeks post-closure surgery
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proteomic analysis
Time Frame: 1 year post-closure surgery
|
Amount of bacteria present in frozen tissue that was collected at treatment day 1 will be determined and compared between groups using a two sample t-test.
|
1 year post-closure surgery
|
|
Bioburden assessment
Time Frame: Through study completion, approximately 5 months
|
Photos of the wound will be taken with a specialized bioburden camera, which can pick up on bacterial load of the wound.
Photos will be taken before debridement, after debridement, after every dressing change, and on the day of surgery.
|
Through study completion, approximately 5 months
|
|
Wound characteristic assessments
Time Frame: 1 year post-closure surgery
|
Wound characteristics collected by the 3D imaging as well as bioburden collected by the bioburden camera will be compared between the control and study groups.
Each respective comparison will involve 2 independent sample t-tests.
|
1 year post-closure surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Robert Galiano, MD, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STU00216075
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.